ARVIND.NS(ARVIND.NS)
ARVIND.NS
No analyst ratings available
No analyst price targets available for ARVIND.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $112.91B | $126.25B | $139.17B | $144.78B |
| Low | $110.23B | $113.58B | $130.28B | $135.53B |
| High | $115.22B | $131.47B | $143.54B | $149.33B |
| EBITDA Avg | $12.74B | $15.05B | $17.25B | $19.51B |
| Low | $11.70B | $14.31B | $16.32B | $18.42B |
| High | $14.22B | $16.46B | $17.71B | $20.04B |
| EBIT Avg | $9.48B | $11.39B | $13.17B | $15.04B |
| Low | $8.44B | $10.65B | $12.23B | $13.95B |
| High | $10.96B | $12.80B | $13.63B | $15.57B |
| Net Income Avg | $5.37B | $6.73B | $7.99B | $9.31B |
| Low | $4.64B | $6.20B | $7.32B | $8.53B |
| High | $6.42B | $7.72B | $8.31B | $9.69B |
| EPS Avg | $20.49 | $25.66 | $30.46 | $35.50 |
| Low | $17.69 | $23.65 | $27.93 | $32.55 |
| High | $24.48 | $29.47 | $31.70 | $36.95 |
| Analysts (Rev / EPS) | 7 / 8 | 8 / 8 | 4 / 3 | 4 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $27.65B | $29.10B | $32.48B |
| Low | $27.03B | $28.55B | $31.81B |
| High | $28.26B | $29.66B | $33.15B |
| EBITDA Avg | $3.29B | $3.45B | $4.47B |
| Low | $3.24B | $3.39B | $4.39B |
| High | $3.34B | $3.50B | $4.55B |
| EBIT Avg | $2.35B | $2.49B | $3.49B |
| Low | $2.29B | $2.44B | $3.41B |
| High | $2.40B | $2.55B | $3.58B |
| Net Income Avg | $1.34B | $1.44B | $2.15B |
| Low | $1.30B | $1.40B | $2.09B |
| High | $1.37B | $1.48B | $2.21B |
| EPS Avg | $5.10 | $5.50 | $8.20 |
| Low | $4.96 | $5.35 | $7.98 |
| High | $5.24 | $5.65 | $8.42 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 | 1 / 1 |